Our results showed that IDO and IL-10 mRNA levels were increased about 27.99 fold and 8.54 fold in cancer patients’ cells over control cells, respectively, but ARG1 levels were increased by 1.68 fold (Figure 3A). The gene discussed is IL10; the disease is cancer.